Eli Lilly and Co. received praise from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for its antibody …
Eli Lilly & Co. said new data showed that treatment with two of its antibody therapies lowered COVID-19-related hospitalizations and deaths in high-risk …
Shares of Eli Lilly & Co. rose as much as 5% in Tuesday’s pre-market session after the US Food and Drug Administration (FDA) …
Eli Lilly (LLY) has been awarded a $312.5 million firm-fixed-price contract from the US army for the procurement of its monoclonal antibody therapeutic …
Eli Lilly & Co. has struck a $375 million agreement with the US government to supply 300,000 vials of its bamlanivimab (LY-CoV555), an investigational …
Eli Lilly & Co. announced on Monday that it will stop a US-based clinical trial for its COVID-19 antibody treatment after data found …
Eli Lilly & Co. announced a definitive agreement to snap up privately-held biotechnology company Disarm Therapeutics for $135 million, in a bid to …
Eli Lilly’s (LLY) Phase 3 trial of its leading monoclonal antibody coronavirus treatment has been paused by the US FDA over potential safety …
Eli Lilly & Co. has entered into an agreement with the Bill & Melinda Gates Foundation, for future supply of the US drugmaker’s …
Eli Lilly said it submitted an initial request to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its …
